Difference between revisions of "Unfractionated heparin"

(Adult Dosing)
(26 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Background==
+
==General==
*Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin
+
*Type: Anticoagulant
*Half-life is 30-150min
+
*Dosage Forms: IV, SC
 +
*Common Trade Names: Heparin
 +
 
 +
==Adult Dosing==
 +
*See [https://depts.washington.edu/anticoag/home/content/heparin-infusion-guidelines University of Washington pharmacy heparin infusion guidelines]
 +
===Thromboembolism===
 +
*Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)
 +
*Then drip: 18 units/kg/h IV (MAX: 1,000 units/h)
 +
*Adjust dose to target aPTT levels based on nomogram
 +
 
 +
==Pediatric Dosing==
 +
*IV infusion
 +
**Initial loading dose 75 units/kg given over 10 minutes
 +
**Initial maintenance dose 20 units/kg/hour and adjest per local policy
 +
 
 +
==Special Populations==
 +
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
 +
*[[Lactation risk categories|Lactation risk]]: Infant risk minimal
 +
*Renal Dosing
 +
**No adjustment
 +
*Hepatic Dosing
 +
**No adjustment
 +
 
 +
==Contraindications==
 +
*Allergy to class/drug
 +
*33% of patients develop some form of bleeding complication; 2-6% develop major bleeding
 +
*Heparin-Induced Thrombocytopenia
 +
*See [[HIT (Heparin-Induced Thrombocytopenia)]]
 +
 
 +
===Risk Factors for Major Bleeding Complication===
 +
*Recent surgery or trauma
 +
*Renal failure
 +
*Alcoholism
 +
*Malignancy
 +
*Liver failure
 +
*Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs
 +
 
 +
==Pharmacology==
 +
*Half-life: 1.5 hrs
 +
*Metabolism: Hepatic
 +
*Excretion: Urine
 +
*Mechanism of Action:
 +
**Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin
 +
*Anticoagulation effect lasts up to 3hr after stopping infusion
 
*Must give IV (not subq) for acute thromboembolic disease
 
*Must give IV (not subq) for acute thromboembolic disease
*Safe in pregnancy
+
**Unpredictable anticoagulation effect
*Unpredictable anticoagulation effect
+
**Must monitor with PTT; therapeutic range is 1.5-2.5x normal value
**Must monitor w/ PTT; therapeutic range is 1.5-2.5x normal value
 
 
 
==Treatment ==
 
#See:
 
##[[DVT]]
 
##[[PE]]
 
##[[NSTEMI]]
 
##[[STEMI]]
 
  
 
==See Also==
 
==See Also==
*[[Low Molecular Weight Heparin]]
+
*[[Unfractionated heparin reversal]]
 +
*[[Coagulopathy (main)]]
 +
*[[Low molecular weight heparin]]
  
==Source ==
+
==References==
Tintinalli
+
<references/>
  
[[Category:Heme/Onc]]
+
[[Category:Pharmacology]]

Revision as of 19:08, 20 April 2019

General

  • Type: Anticoagulant
  • Dosage Forms: IV, SC
  • Common Trade Names: Heparin

Adult Dosing

Thromboembolism

  • Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)
  • Then drip: 18 units/kg/h IV (MAX: 1,000 units/h)
  • Adjust dose to target aPTT levels based on nomogram

Pediatric Dosing

  • IV infusion
    • Initial loading dose 75 units/kg given over 10 minutes
    • Initial maintenance dose 20 units/kg/hour and adjest per local policy

Special Populations

Contraindications

Risk Factors for Major Bleeding Complication

  • Recent surgery or trauma
  • Renal failure
  • Alcoholism
  • Malignancy
  • Liver failure
  • Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs

Pharmacology

  • Half-life: 1.5 hrs
  • Metabolism: Hepatic
  • Excretion: Urine
  • Mechanism of Action:
    • Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin
  • Anticoagulation effect lasts up to 3hr after stopping infusion
  • Must give IV (not subq) for acute thromboembolic disease
    • Unpredictable anticoagulation effect
    • Must monitor with PTT; therapeutic range is 1.5-2.5x normal value

See Also

References